{"id":1678,"date":"2021-11-04T09:34:35","date_gmt":"2021-11-04T08:34:35","guid":{"rendered":"https:\/\/svas.it\/?page_id=1678"},"modified":"2025-10-27T09:36:53","modified_gmt":"2025-10-27T08:36:53","slug":"history","status":"publish","type":"page","link":"https:\/\/svas.it\/en\/about-us\/history\/","title":{"rendered":"History"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
Home<\/a><\/span><\/span><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\r\n
\r\n
<\/div> \r\n
July 2025<\/div><\/div>
<\/i><\/div>
<\/div>
Mehos Acquisition<\/div>

Svas Biosana has completed the acquisition of a 51% stake in Arese-based Mehos. The company specializes in the marketing of medical devices, with a primary focus on public healthcare facilities.<\/p><\/div><\/div><\/div>

March 2025<\/div><\/div>
<\/i><\/div>
<\/div>
Acquisition of Hermes Pharma and Megapharm<\/div>

Svas Biosana completed the acquisition of Hermes Pharma and Megapharm.<\/p>

The acquisition of 100% of Hermes Pharma was completed through Mark Medical (a wholly-owned subsidiary), while the acquisition of 100% of Megapharm was completed through Levante (a wholly-owned subsidiary).<\/p>

Both Acquired Companies are active in the marketing of medical devices in Serbia.<\/p><\/div><\/div><\/div>

2022<\/div><\/div>
<\/i><\/div>
<\/div>
Acquisition of the Bormia Group<\/div>

SVAS Biosana acquires the Bormia Group, a company active in the distribution of specialized medical devices for public and private clients in the Slovenian, Croatian, Serbian, and Bosnian healthcare systems.<\/p><\/div><\/div><\/div>

2021<\/div><\/div>
<\/i><\/div>
<\/div>
Listing on Euronext Growth Milan<\/div>

Listing on Euronext Growth Milan, multilateral trading system organised and managed by Borsa Italiana S.p.A.<\/p><\/div><\/div><\/div>

2020<\/div><\/div>
<\/i><\/div>
<\/div>
Split of the pharmaceutical sector<\/div>

Split of Industria Farmaceutica Galenica Senese Srl<\/p><\/div><\/div><\/div>

2019<\/div><\/div>
<\/i><\/div>
<\/div>
Associates stocks re-purchase<\/div>

The Perillo family reacquired the shares held by Fondo Elite Private Equity.<\/p><\/div><\/div><\/div>

2019<\/div><\/div>
<\/i><\/div>
<\/div>
Elite Basket Bond Export<\/div>

SVAS Biosana is one of the top 10 issuers of a new financial instrument: the ELITE Basket Bond Export.<\/p><\/div><\/div><\/div>

2017<\/div><\/div>
<\/i><\/div>
<\/div>
Elite Basket Bond<\/div>

In 2017 SVAS Biosana participates as an issuer to the first the first ELITE Basket Bond, along with other nine companies in the ELITE programme.<\/p><\/div><\/div><\/div>

2015<\/div><\/div>
<\/i><\/div>
<\/div>
Mark Medical Group<\/div>

In 2015, SVAS Biosana acquired Mark Medical, a leading distributor of medical devices in Slovenia, Croatia, Serbia, Bosnia and Herzegovina.<\/p><\/div><\/div><\/div>

2012<\/div><\/div>
<\/i><\/div>
<\/div>
Elite project<\/div>

In 2012, SVAS Biosana became one of the first 30 companies to take part in Borsa Italiana\u2019s ELITE project. Fondo Atlante Private Equity entered the group\u2019s share capital, acquiring a minority stake.<\/p><\/div><\/div><\/div>

2004<\/div><\/div>
<\/i><\/div>
<\/div>
A new acquisition<\/div>

In 2004, it acquired the business of Fabbrica Italiana di Medicazione (FIM).<\/p><\/div><\/div><\/div>

1990<\/div><\/div>
<\/i><\/div>
<\/div>
A further leap<\/div>

At the same time, it started the production of custom pack turning from a distribution company into a major industrial company with its own product catalogue.
From the 1990s onwards, the real leap in size began with a series of acquisitions that allowed the company to increase its know-how and product range.
In 1996, SVAS Biosana took over the factory Vincenzo Sorrentino e Figli, a company operating in the segment of cotton-derived products for sanitary and cosmetic use.<\/p><\/div><\/div><\/div>

1980<\/div><\/div>
<\/i><\/div>
<\/div>
A growit path<\/div>

In 1985 SVAS Biosana acquired Industria Farmaceutica Galenica Senese Srl, and began production of injectable solutions.
In 1989, SVAS Biosana completed its first industrial project: starting the production of incontinence aids.<\/p><\/div><\/div><\/div>

1972<\/div><\/div>
<\/i><\/div>
<\/div>
Foundation<\/div>

SVAS Biosana was founded in 1972 by the Perillo family, with the initial aim of supplying medical devices across South Italy.
The desire to grow, to innovate and to expand its services was in the company\u2019s DNA from the very beginning. As early as the 1980s, SVAS Biosana began its growth with targeted acquisitions, which in 40 years led it to become a leading company in Italy and abroad.<\/p><\/div><\/div><\/div><\/div>\r\n

<\/div>\r\n <\/div>